https://www.diabesityrounds.com/a/sglt2-inhibitor-use-associated-with-small-rises-in-haemoglobin-and-haematocrit-8Diabesity Roundsen2026-10-25T20:02:40.396ZSGLT2 inhibitor use associated with small rises in haemoglobin and haematocrit, 85 trialshttps://www.diabesityrounds.com/a/oral-glp-1-agonists-early-hba1c-data-regulators-acting-safety-data-still-missingDiabesity Roundsen2026-10-25T02:03:07.359ZOral GLP-1 agonists: early HbA1c data, regulators acting, safety data still missing